AMDA News
Archived Headlines
- Amedica prices IPO at $5.75, well below the revised range 02/13/14
- Amedica decreases range to $8 to $10 and increases shares offered 02/12/14
- 9 US IPOs planned for the week of Feb 10 02/10/14
- US IPO Recap: Ultragenyx doubles and Dicerna triples in home-run week for biotech IPOs 02/03/14
- Medical device company Amedica sets terms for $35 million IPO 01/29/14
See more
Spinal device company K2M Group sets terms for $150 million IPO
K2M Group Holdings, which develops and sells medical devices for use in spinal surgeries, announced terms for its IPO on Tuesday. The Leesburg, VA-based company plans to raise $150 million by offering about 8.8 million shares at a price range of $16 to $18. At...read more
Spinal device company K2M Group files for a $100 million IPO
K2M Group Holdings, which develops and sells medical devices for use in spine surgeries, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Leesburg, VA-based company, which was founded in 2004 and booked $158 million in...read more
US IPO Recap: Wave goodbye to the biotech wave as tech prepares to take over
Last week marked the end of the greatest amount of biotech activity across a two-week stretch in over a decade (14 pricings from 1/29 to 2/11). However, without any superstar performers like January’s Dicerna (DRNA; up 160%) or Ultragenyx (RARE; 110%),...read more
Health IPOs down 1% and housing IPOs trade up after heavy discount
The week’s five health sector IPOs have produced lackluster returns; together they are down 1% on average from their IPO prices. Amedica (AMDA), which creates improved spine, hip and joint replacements, dropped 6% today after pricing at the largest...read more